SCHEMBL18178718

SCHEMBL18178718

CCC(=O)Oc1cccc(CC)c1COc1cc(C)c(C)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 6/20 0.39
ACHE P22303 1/20 0.38
HPGD P15428 3/20 0.36
HSD17B10 Q99714 3/20 0.36
MAPK1 P28482 3/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
ACLY P53396 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
ALDH1A1 P00352 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GUCY1B2 O75343 6/20 0.34
GUCY1A2 P33402 6/20 0.34
GUCY1A1 Q02108 6/20 0.34
GUCY1B1 Q02153 6/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156297 0.94 ACHE (0.37) MRGPRX4ACHEHPGDHSD17B10MAPK1
SCHEMBL18178545 0.94 MRGPRX4 (0.40) MRGPRX4ACHEHPGDHSD17B10MAPK1
SCHEMBL18178743 0.93 MRGPRX4 (0.37) MRGPRX4ACHEHPGDHSD17B10MAPK1
SCHEMBL18178712 0.92 MRGPRX4 (0.37) MRGPRX4ACHEHPGDHSD17B10MAPK1
SCHEMBL18178646 0.91 MRGPRX4 (0.40) MRGPRX4ACHEMAPK1ALDH1A1L3MBTL1
SCHEMBL18178706 0.90 MRGPRX4 (0.40) MRGPRX4ACHEACLYSLC22A12ALDH1A1
SCHEMBL18178709 0.90 SLC22A12 (0.41) MRGPRX4ACHEHPGDHSD17B10MAPK1
SCHEMBL18178348 0.89 MRGPRX4 (0.38) MRGPRX4HPGDHSD17B10MAPK1KDM4E
SCHEMBL18181976 0.89 ACLY (0.36) MRGPRX4ACHEHPGDHSD17B10MAPK1
SCHEMBL18178765 0.89 ACHE (0.40) MRGPRX4ACHEHPGDHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 MRGPRX4 167/4885ACHE 460/4885HPGD 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.